These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 6391086

  • 1. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation.
    Sølling J.
    Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):213-20. PubMed ID: 6391086
    [Abstract] [Full Text] [Related]

  • 2. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C, Suhara Y, Kikkawa Y.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [Abstract] [Full Text] [Related]

  • 3. Circulating immune complexes in glomerulonephritis: a longitudinal study.
    Sølling J.
    Clin Nephrol; 1983 Oct; 20(4):177-89. PubMed ID: 6139194
    [Abstract] [Full Text] [Related]

  • 4. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy.
    Doi T, Kanatsu K, Sekita K, Yoshida H, Nagai H, Hamashima Y.
    J Immunol Methods; 1984 Apr 13; 69(1):95-104. PubMed ID: 6371143
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V, Premzl A, Skoberne M, Malovrh T, Kveder R, Kaplan-Pavlovcic S, Kotnik A, Stiblar-Martincic D.
    Croat Med J; 2003 Dec 13; 44(6):707-11. PubMed ID: 14652883
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation?
    van Son WJ, van der Bij W, Tegzess AM, Anema J, van der Giessen M, van der Hem GK, Marrink J, The TH.
    Clin Immunol Immunopathol; 1989 Jan 13; 50(1 Pt 1):109-21. PubMed ID: 2535976
    [Abstract] [Full Text] [Related]

  • 15. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
    Swaak AJ, Groenwold J, Hannema A, Hack CE.
    Rheumatol Int; 1985 Jan 13; 5(5):215-20. PubMed ID: 3877968
    [Abstract] [Full Text] [Related]

  • 16. Circulating immune complexes in membranoproliferative glomerulonephritis.
    Davis CA, Marder H, West CD.
    Kidney Int; 1981 Dec 13; 20(6):728-32. PubMed ID: 6801370
    [Abstract] [Full Text] [Related]

  • 17. Demonstration of C3d deposits in membranous nephropathy.
    Doi T, Kanatsu K, Nagai H, Suehiro F, Kuwahara T, Hamashima Y.
    Nephron; 1984 Dec 13; 37(4):232-5. PubMed ID: 6379483
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT, Lambris JD, Tsokos GC, Burger R, Bitter-Suermann D, Tamerius JD, Dixon FJ, Theofilopoulos AN.
    J Clin Invest; 1985 Oct 13; 76(4):1418-26. PubMed ID: 2932466
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.